Among these five CRRs, SLC31A1 was associated with chemoresistance to platinum in osteosarcoma (Cheng et al., 2020), lung cancer (Wang et al., 2021b), and ovarian cancer (Wu et al., 2021b). Here, SLC31A1 is linked to osteosarcoma.